Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03001 |
| Species: | Mus musculus |
| Position : | chr11:10996600-10999794 |
| Year: | 2018 |
| Title: | Sex reversal following deletion of a single far upstream enhancer of Sox9 |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | sex reversal |
| PMID: | 29903884 |
| MONDO: | MONDO:0008637 |
| Tissue: | Testis |
| Tissue Ontology ID: | UBERON:0000473 |
| Cell Source: | Sertoli cell precursors |
| CVCL ID: | |
| Cell Type: | Sertoli cell precursor |
| Cell Ontology ID: | CL:0000216 |
| Experiment Type: | Developmental biology assay, Functional genomics assay, Epigenomic profiling assay, Genome editing assay, Transcriptional regulation assay, In vivo functional assay |
| High Throughput Method: | ChIP-seq, DNase-seq, ATAC-seq |
| Low Throughput Method: | CRISPR-Cas9 enhancer deletion, RT-RT-qPCR, ChIP-RT-qPCR, Immunofluorescence, Genotyping PCR, Sanger Sequencing |
| Target gene : | Sox9 |
| TF name : | Sry; Sox9; Nr5A1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03061 | chr11:10997900-10999300 | Testis | Sertoli cell precursor | sex reversal |